rPeptide

🔬Citation Break!📖 This citation investigates the effects of oligomeric Tau on the blood-brain barrier. rPeptide's Tau-441 (Cat# T-1001) was used to prepare oligomers before being added to primary mice cerebral endothelial cells. Cell-based experiments are just one set of experiments our Tau products are suitable for. Paper: https://t.ly/_gmeZ Tau-441: https://t.ly/Q1i3C #Research #Development #Experiment #Tau441 #Recombinant #rPeptide

We have everything we need to create something incredible. Here's to a great week! 🔥 #NewWeek #MotivationalMonday #rPeptide

Our October Raffle Riddle winner is Jackie! 🎉 Please check your email to claim your prize. Thank you to everyone who participated! #WinnerAnnouncement #rPeptide #Raffle #Prize #StayTuned #November

Our October Raffle Riddle answer is...🥁🥁🥁

🔬Citation Break!📖 This citation investigates the impact of nano plastics on Parkinson’s Disease by studying their physiological and neurotoxic effects on human cells. Our monomeric Alpha-Synuclein (S-1001) was used to generate fibrils for further use in cell-based experimentation and aggregation assays. Paper: https://rb.gy/ruw7yo Alpha-Synuclein: https://rb.gy/il6ts4 #Research #Development #Experiment #AlphaSynuclein #Parkinsons #Recombinant #rPeptide

Just having some Friday fun! #SciencePuns #LabLaughs #FunFriday #rPeptide

Do you know the answer to this October Raffle Riddle?! 🤔 #Raffle #Riddle #Prize #rPeptide #Fun

🔬Citation Break!📖 This citation investigates the potential use of nanoparticles as therapeutics. Rather than more traditional targets such as antibodies, NPs can play an important role in fighting various diseases including Alzheimer's and Parkinson’s Disease or diabetes. rPeptide's Beta-Amyloid (1-42) and Alpha-Synuclein were used to generate amyloids for further experimentation and in assays such as thioflavin or TEM. The authors also made use of our contract research services to generate the custom-made Alexa-488 labeled Alpha-Synuclein for their experiments. Paper: https://t.ly/dD_L0 Custom Services: https://t.ly/zyp0l #Research #Development #Experiment #AlphaSynuclein #BetaAmyloid #CustomPeptide #Recombinant #Peptide

Researchers are testing a new Alzheimer’s treatment that uses light and sound therapy to synchronize gamma waves in the brain. Early trials show it may help slow cognitive decline without serious side effects. This approach is now under review in larger clinical trials to confirm its effectiveness. 🧠 https://t.ly/iEVPS #AlzheimersResearch #Neuroscience #Innovation #rPeptide

🔬Citation Break!📖 This citation highlights the differences between Alzheimer's Disease, Alzheimer's Disease with Lewy bodies, and Parkinson’s Disease with dementia. Several of rPeptide’s products were used during the research, such as Alpha-Synuclein, all six major Tau isoforms, and our Tau Protein Ladder. These products were used in an array of experiments including antibody selection, dot blotting, western blots, and testing against brain tissue homogenate samples. rPeptide offers several native, mutant, and labeled options of the Synuclein and Tau lines of products. Paper: https://t.ly/6DR6O Products: https://t.ly/wJNSM #Research #Development #Experiment #AlphaSynuclein #Tau #Isoforms #ProteinLadder #Recombinant #Peptide #rPeptide